OMC
BIIB icon

Old Mission Capital’s Biogen BIIB Stock Holding History

Old Mission Capital’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-19,823
Closed -$5.09M – 1327
2023
Q3 		$5.09M Buy
+19,823
New +$5.3M 0.11% 166
2018
Q1 		– Sell
-1,768
Closed -$563K – 386
2017
Q4 		$563K Buy
+1,768
New +$567K 0.04% 214

Other funds holding BIIB

Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
ClearBridge Investments
ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Old Mission Capital's BIIB Position: Q4 2023 in Review

Old Mission Capital sold out of Biogen (BIIB) in Q4 2023, closing a stake of 19,823 shares — an estimated $5.09M sold.

Old Mission Capital first reported a position in BIIB in Q4 2017 and held it in 2 quarters. The position peaked at $5.09M in Q3 2023. 1,003 funds tracked by Wall St. Rank hold BIIB as of Q4 2023.

  • Old Mission Capital reported no remaining Biogen position as of Q4 2023 after selling out during the quarter.
  • Old Mission Capital sold 19,823 Biogen shares in Q4 2023, an estimated $5.09M.
  • Old Mission Capital first reported a position in Biogen in Q4 2017 and held it in 2 quarters.
  • Old Mission Capital's Biogen position peaked at $5.09M in Q3 2023.
  • 1,003 funds tracked by Wall St. Rank held Biogen as of Q4 2023.

Based on Old Mission Capital's 13F filing for Q4 2023, filed 14 Feb 2024.